Global Apheresis Market Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387410
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 3
The Global market for Apheresis is expected to reach $2.3 billion by the end of 2020 growing at a CAGR of around 9.8% from 2014 to 2021. Apheresis is a process of removing the blood from the donor or patient and sending it to an apparatus which separates out one particular constituent and returns the remainder to the body. The procedure involves connecting the blood in the patients vein through tubing to a machine that separates the blood components. After the separation the desired component of blood is taken, while the rest of the blood components are reinforced back into the patient. The components are removed from the body using centrifugation process and membrane segregation. The entire procedure is painless and takes approximately two hours.

The Global Apheresis Market is segmented on the basis of Type of Apheresis (Leukapheresis, Plasmapheresis, Plateletpheresis, Erythrocytapheresis, Extracorporeal Photopheresis and Low Density Lipid Apheresis), Technology (Centrifugation and Membrane segregation), Applications (Cardiovascular Diseases [Acute Myocarditis and Peripheral Vascular Disease], Hematological & Oncological Diseases [Heparin induced Thrombocytopenia (HIT), Sickle Cell Disease (SCD) and Acute Myeloid Leukemia (AML)], Renal Diseases, Neurological Diseases and Multiorgan Failure) and Region (North America, Europe, Asia Pacific and Rest of the World).

Drivers

Rise in the number of accidents leading to demand for blood components, increasing incidences of chronic diseases and development of new apheresis techniques are some of the factors enhancing the market growth.

Challenges

Risk of blood getting infected, lack of skilled personnel to carry out the procedure and unavailability of both donor & specific blood group are some of the factors hampering the growth of the market.

This Report Offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.
Market analysis for the Global Apheresis Market, with region specific assessments and competition analysis on a global and regional scale.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
Identification and analysis of the Macro and Micro factors that affect the Global Apheresis Market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Rise in the number of accidents leading to demand for blood components
3.2.2 Increasing incidences of chronic diseases
3.2.3 Development of new apheresis techniques
3.3 Market Restraints
3.3.1 Risk of blood getting infected
3.3.2 Lack of skilled personnel to carry out the procedure
3.3.3 Unavailability of both donor & specific blood group
3.4 Market Opportunitites
3.5 Market Threats
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Global Apheresis Market
5.1.1 By Type of Apheresis
5.1.1.1 Leukapheresis
5.1.1.2 Plasmapheresis
5.1.1.3 Plateletpheresis
5.1.1.4 Erythrocytapheresis
5.1.1.5 Extracorporeal Photopheresis
5.1.1.6 Low Density Lipid Apheresis
5.1.2 By Technology
5.1.2.1 Centrifugation
5.1.2.2 Membrane segregation
5.1.3 By Applications
5.1.3.1 Cardiovascular Diseases
5.1.3.1.1 Acute Myocarditis
5.1.3.1.2 Peripheral Vascular Disease
5.1.3.2 Hematological & Oncological Diseases
5.1.3.2.1 Heparin induced Thrombocytopenia (HIT)
5.1.3.2.2 Sickle Cell Disease (SCD)
5.1.3.2.3 Acute Myeloid Leukemia (AML)
5.1.3.3 Renal Diseases
5.1.3.4 Neurological Diseases
5.1.3.5 Multiorgan Failure
5.1.4 By Geography
5.1.4.1 North America
5.1.4.1.1 USA
5.1.4.1.2 Canada
5.1.4.1.3 Mexico
5.1.4.2 Europe
5.1.4.2.1 UK
5.1.4.2.2 Germany
5.1.4.2.3 France
5.1.4.2.4 Italy
5.1.4.2.5 Spain
5.1.4.3 Asia Pacific
5.1.4.3.1 China
5.1.4.3.2 Japan
5.1.4.3.3 India
5.1.4.3.4 Australia
5.1.4.4 ROW
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Terumo
7.2 Asahi Kasei
7.3 HemaCare
7.4 Fenwal
7.5 Haemonetics
7.6 Medica
7.7 Kaneka
7.8 Cerus
7.9 Therakos
7.10 Kawasumi Laboratories

List of Tables

1: Global Apheresis Market($ million)(2017 - 2022).
2: Global Apheresis Market-By Type of Apheresis-($ million)(2017 - 2022).
3: Global Apheresis Market-By Type of Apheresis-Leukapheresis-($ million)(2017 - 2022).
4: Global Apheresis Market-By Type of Apheresis-Plasmapheresis-($ million)(2017 - 2022).
5: Global Apheresis Market-By Type of Apheresis-Plateletpheresis-($ million)(2017 - 2022).
6: Global Apheresis Market-By Type of Apheresis-Erythrocytapheresis-($ million)(2017 - 2022).
7: Global Apheresis Market-By Type of Apheresis-Extracorporeal Photopheresis-($ million)(2017 - 2022).
8: Global Apheresis Market-By Type of Apheresis-Low Density Lipid Apheresis-($ million)(2017 - 2022).
9: Global Apheresis Market-By Technology-($ million)(2017 - 2022).
10: Global Apheresis Market-By Technology-Centrifugation-($ million)(2017 - 2022).
11: Global Apheresis Market-By Technology-Membrane segregation-($ million)(2017 - 2022).
12: Global Apheresis Market-By Applications-($ million)(2017 - 2022).
13: Global Apheresis Market-By Applications-Cardiovascular Diseases-($ million)(2017 - 2022).
14: Global Apheresis Market-By Applications-Cardiovascular Diseases-Acute Myocarditis-($ million)(2017 - 2022).
15: Global Apheresis Market-By Applications-Cardiovascular Diseases-Peripheral Vascular Disease-($ million)(2017 - 2022).
16: Global Apheresis Market-By Applications-Hematological & Oncological Diseases-($ million)(2017 - 2022).
17: Global Apheresis Market-By Applications-Hematological & Oncological Diseases-Heparin induced Thrombocytopenia (HIT)-($ million)(2017 - 2022).
18: Global Apheresis Market-By Applications-Hematological & Oncological Diseases-Sickle Cell Disease (SCD)-($ million)(2017 - 2022).
19: Global Apheresis Market-By Applications-Hematological & Oncological Diseases-Acute Myeloid Leukemia (AML)-($ million)(2017 - 2022).
20: Global Apheresis Market-By Applications-Renal Diseases-($ million)(2017 - 2022).
21: Global Apheresis Market-By Applications-Neurological Diseases-($ million)(2017 - 2022).
22: Global Apheresis Market-By Applications-Multiorgan Failure-($ million)(2017 - 2022).
23: North American Apheresis Market($ million)(2017 - 2022).
24: North American Apheresis Market-By Type of Apheresis-($ million)(2017 - 2022).
25: North American Apheresis Market-By Type of Apheresis-Leukapheresis-($ million)(2017 - 2022).
26: North American Apheresis Market-By Type of Apheresis-Plasmapheresis-($ million)(2017 - 2022).
27: North American Apheresis Market-By Type of Apheresis-Plateletpheresis-($ million)(2017 - 2022).
28: North American Apheresis Market-By Type of Apheresis-Erythrocytapheresis-($ million)(2017 - 2022).
29: North American Apheresis Market-By Type of Apheresis-Extracorporeal Photopheresis-($ million)(2017 - 2022).
30: North American Apheresis Market-By Type of Apheresis-Low Density Lipid Apheresis-($ million)(2017 - 2022).
31: North American Apheresis Market-By Technology-($ million)(2017 - 2022).
32: North American Apheresis Market-By Technology-Centrifugation-($ million)(2017 - 2022).
33: North American Apheresis Market-By Technology-Membrane segregation-($ million)(2017 - 2022).
34: North American Apheresis Market-By Applications-($ million)(2017 - 2022).
35: North American Apheresis Market-By Applications-Cardiovascular Diseases-($ million)(2017 - 2022).
36: North American Apheresis Market-By Applications-Cardiovascular Diseases-Acute Myocarditis-($ million)(2017 - 2022).
37: North American Apheresis Market-By Applications-Cardiovascular Diseases-Peripheral Vascular Disease-($ million)(2017 - 2022).
38: North American Apheresis Market-By Applications-Hematological & Oncological Diseases-($ million)(2017 - 2022).
39: North American Apheresis Market-By Applications-Hematological & Oncological Diseases-Heparin induced Thrombocytopenia (HIT)-($ million)(2017 - 2022).
40: North American Apheresis Market-By Applications-Hematological & Oncological Diseases-Sickle Cell Disease (SCD)-($ million)(2017 - 2022).
41: North American Apheresis Market-By Applications-Hematological & Oncological Diseases-Acute Myeloid Leukemia (AML)-($ million)(2017 - 2022).
42: North American Apheresis Market-By Applications-Renal Diseases-($ million)(2017 - 2022).
43: North American Apheresis Market-By Applications-Neurological Diseases-($ million)(2017 - 2022).
44: North American Apheresis Market-By Applications-Multiorgan Failure-($ million)(2017 - 2022).
45: European Apheresis Market($ million)(2017 - 2022).
46: European Apheresis Market-By Type of Apheresis-($ million)(2017 - 2022).
47: European Apheresis Market-By Type of Apheresis-Leukapheresis-($ million)(2017 - 2022).
48: European Apheresis Market-By Type of Apheresis-Plasmapheresis-($ million)(2017 - 2022).
49: European Apheresis Market-By Type of Apheresis-Plateletpheresis-($ million)(2017 - 2022).
50: European Apheresis Market-By Type of Apheresis-Erythrocytapheresis-($ million)(2017 - 2022).
51: European Apheresis Market-By Type of Apheresis-Extracorporeal Photopheresis-($ million)(2017 - 2022).
52: European Apheresis Market-By Type of Apheresis-Low Density Lipid Apheresis-($ million)(2017 - 2022).
53: European Apheresis Market-By Technology-($ million)(2017 - 2022).
54: European Apheresis Market-By Technology-Centrifugation-($ million)(2017 - 2022).
55: European Apheresis Market-By Technology-Membrane segregation-($ million)(2017 - 2022).
56: European Apheresis Market-By Applications-($ million)(2017 - 2022).
57: European Apheresis Market-By Applications-Cardiovascular Diseases-($ million)(2017 - 2022).
58: European Apheresis Market-By Applications-Cardiovascular Diseases-Acute Myocarditis-($ million)(2017 - 2022).
59: European Apheresis Market-By Applications-Cardiovascular Diseases-Peripheral Vascular Disease-($ million)(2017 - 2022).
60: European Apheresis Market-By Applications-Hematological & Oncological Diseases-($ million)(2017 - 2022).
61: European Apheresis Market-By Applications-Hematological & Oncological Diseases-Heparin induced Thrombocytopenia (HIT)-($ million)(2017 - 2022).
62: European Apheresis Market-By Applications-Hematological & Oncological Diseases-Sickle Cell Disease (SCD)-($ million)(2017 - 2022).
63: European Apheresis Market-By Applications-Hematological & Oncological Diseases-Acute Myeloid Leukemia (AML)-($ million)(2017 - 2022).
64: European Apheresis Market-By Applications-Renal Diseases-($ million)(2017 - 2022).
65: European Apheresis Market-By Applications-Neurological Diseases-($ million)(2017 - 2022).
66: European Apheresis Market-By Applications-Multiorgan Failure-($ million)(2017 - 2022).
67: Asia Pacific Apheresis Market($ million)(2017 - 2022).
68: Asia Pacific Apheresis Market-By Type of Apheresis-($ million)(2017 - 2022).
69: Asia Pacific Apheresis Market-By Type of Apheresis-Leukapheresis-($ million)(2017 - 2022).
70: Asia Pacific Apheresis Market-By Type of Apheresis-Plasmapheresis-($ million)(2017 - 2022).
71: Asia Pacific Apheresis Market-By Type of Apheresis-Plateletpheresis-($ million)(2017 - 2022).
72: Asia Pacific Apheresis Market-By Type of Apheresis-Erythrocytapheresis-($ million)(2017 - 2022).
73: Asia Pacific Apheresis Market-By Type of Apheresis-Extracorporeal Photopheresis-($ million)(2017 - 2022).
74: Asia Pacific Apheresis Market-By Type of Apheresis-Low Density Lipid Apheresis-($ million)(2017 - 2022).
75: Asia Pacific Apheresis Market-By Technology-($ million)(2017 - 2022).
76: Asia Pacific Apheresis Market-By Technology-Centrifugation-($ million)(2017 - 2022).
77: Asia Pacific Apheresis Market-By Technology-Membrane segregation-($ million)(2017 - 2022).
78: Asia Pacific Apheresis Market-By Applications-($ million)(2017 - 2022).
79: Asia Pacific Apheresis Market-By Applications-Cardiovascular Diseases-($ million)(2017 - 2022).
80: Asia Pacific Apheresis Market-By Applications-Cardiovascular Diseases-Acute Myocarditis-($ million)(2017 - 2022).
81: Asia Pacific Apheresis Market-By Applications-Cardiovascular Diseases-Peripheral Vascular Disease-($ million)(2017 - 2022).
82: Asia Pacific Apheresis Market-By Applications-Hematological & Oncological Diseases-($ million)(2017 - 2022).
83: Asia Pacific Apheresis Market-By Applications-Hematological & Oncological Diseases-Heparin induced Thrombocytopenia (HIT)-($ million)(2017 - 2022).
84: Asia Pacific Apheresis Market-By Applications-Hematological & Oncological Diseases-Sickle Cell Disease (SCD)-($ million)(2017 - 2022).
85: Asia Pacific Apheresis Market-By Applications-Hematological & Oncological Diseases-Acute Myeloid Leukemia (AML)-($ million)(2017 - 2022).
86: Asia Pacific Apheresis Market-By Applications-Renal Diseases-($ million)(2017 - 2022).
87: Asia Pacific Apheresis Market-By Applications-Neurological Diseases-($ million)(2017 - 2022).
88: Asia Pacific Apheresis Market-By Applications-Multiorgan Failure-($ million)(2017 - 2022).
89: Rest of the World Apheresis Market($ million)(2017 - 2022).
90: Rest of the World Apheresis Market-By Type of Apheresis-($ million)(2017 - 2022).
91: Rest of the World Apheresis Market-By Type of Apheresis-Leukapheresis-($ million)(2017 - 2022).
92: Rest of the World Apheresis Market-By Type of Apheresis-Plasmapheresis-($ million)(2017 - 2022).
93: Rest of the World Apheresis Market-By Type of Apheresis-Plateletpheresis-($ million)(2017 - 2022).
94: Rest of the World Apheresis Market-By Type of Apheresis-Erythrocytapheresis-($ million)(2017 - 2022).
95: Rest of the World Apheresis Market-By Type of Apheresis-Extracorporeal Photopheresis-($ million)(2017 - 2022).
96: Rest of the World Apheresis Market-By Type of Apheresis-Low Density Lipid Apheresis-($ million)(2017 - 2022).
97: Rest of the World Apheresis Market-By Technology-($ million)(2017 - 2022).
98: Rest of the World Apheresis Market-By Technology-Centrifugation-($ million)(2017 - 2022).
99: Rest of the World Apheresis Market-By Technology-Membrane segregation-($ million)(2017 - 2022).
100: Rest of the World Apheresis Market-By Applications-($ million)(2017 - 2022).
101: Rest of the World Apheresis Market-By Applications-Cardiovascular Diseases-($ million)(2017 - 2022).
102: Rest of the World Apheresis Market-By Applications-Cardiovascular Diseases-Acute Myocarditis-($ million)(2017 - 2022).
103: Rest of the World Apheresis Market-By Applications-Cardiovascular Diseases-Peripheral Vascular Disease-($ million)(2017 - 2022).
104: Rest of the World Apheresis Market-By Applications-Hematological & Oncological Diseases-($ million)(2017 - 2022).
105: Rest of the World Apheresis Market-By Applications-Hematological & Oncological Diseases-Heparin induced Thrombocytopenia (HIT)-($ million)(2017 - 2022).
106: Rest of the World Apheresis Market-By Applications-Hematological & Oncological Diseases-Sickle Cell Disease (SCD)-($ million)(2017 - 2022).
107: Rest of the World Apheresis Market-By Applications-Hematological & Oncological Diseases-Acute Myeloid Leukemia (AML)-($ million)(2017 - 2022).
108: Rest of the World Apheresis Market-By Applications-Renal Diseases-($ million)(2017 - 2022).
109: Rest of the World Apheresis Market-By Applications-Neurological Diseases-($ million)(2017 - 2022).
110: Rest of the World Apheresis Market-By Applications-Multiorgan Failure-($ million)(2017 - 2022).
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll